Rebecka Hellsten

Summary

Affiliation: Lund University
Country: Sweden

Publications

  1. ncbi request reprint Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3
    Rebecka Hellsten
    Division of Urological Cancers, Department of Clinical Sciences Malmo, Lund University, Malmo, Sweden
    Prostate 68:269-80. 2008
  2. pmc Galiellalactone inhibits stem cell-like ALDH-positive prostate cancer cells
    Rebecka Hellsten
    Division of Urological Cancers, Department of Clinical Sciences, Lund University, Malmo, Sweden
    PLoS ONE 6:e22118. 2011
  3. pmc Galiellalactone Is a Direct Inhibitor of the Transcription Factor STAT3 in Prostate Cancer Cells
    Nicholas Don-Doncow
    From the Division of Urological Cancers, Lund University, SE 205 02 Malmo, Sweden
    J Biol Chem 289:15969-78. 2014
  4. ncbi request reprint A highly conserved protein secreted by the prostate cancer cell line PC-3 is expressed in benign and malignant prostate tissue
    Camilla Valtonen-Andre
    Lund University, Division of Clinical Chemistry, Department of Laboratory Medicine, University Hospital MAS, S 205 02 Malmo, Sweden
    Biol Chem 388:289-95. 2007

Collaborators

Detail Information

Publications4

  1. ncbi request reprint Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3
    Rebecka Hellsten
    Division of Urological Cancers, Department of Clinical Sciences Malmo, Lund University, Malmo, Sweden
    Prostate 68:269-80. 2008
    ..In this study we investigated the in vitro and in vivo effects of the fungal metabolite galiellalactone, a direct inhibitor of Stat3, on PCa cells...
  2. pmc Galiellalactone inhibits stem cell-like ALDH-positive prostate cancer cells
    Rebecka Hellsten
    Division of Urological Cancers, Department of Clinical Sciences, Lund University, Malmo, Sweden
    PLoS ONE 6:e22118. 2011
    ....
  3. pmc Galiellalactone Is a Direct Inhibitor of the Transcription Factor STAT3 in Prostate Cancer Cells
    Nicholas Don-Doncow
    From the Division of Urological Cancers, Lund University, SE 205 02 Malmo, Sweden
    J Biol Chem 289:15969-78. 2014
    ..This further validates galiellalactone as a promising direct STAT3 inhibitor for treatment of castration-resistant prostate cancer. ..
  4. ncbi request reprint A highly conserved protein secreted by the prostate cancer cell line PC-3 is expressed in benign and malignant prostate tissue
    Camilla Valtonen-Andre
    Lund University, Division of Clinical Chemistry, Department of Laboratory Medicine, University Hospital MAS, S 205 02 Malmo, Sweden
    Biol Chem 388:289-95. 2007
    ..Studies on human prostate cancer specimens showed immunohistochemical staining of both tumor and benign glandular cells. Our results suggest that PSMP is an important protein with significance in prostate cancer...